
Ativa os alertas de emprego por e-mail!
Cria um currículo personalizado em poucos minutos
Consegue uma entrevista e ganha mais. Sabe mais
A leading biotherapeutics company in São Paulo seeks a Marketing Analyst to support the Rare Diseases portfolio. Responsibilities include planning and executing data-driven omnichannel campaigns, analyzing performance, and collaborating across teams. Candidates should have a degree in relevant fields, fluency in Portuguese, and strong analytical skills. This role requires creativity, proactivity, and a hands-on approach to engage specialized audiences and support compliance with regulations.
Reporting to the Associate Director, Marketing of our São Paulo sales office, as the Marketing Analyst, you will support CSL’s Rare Diseases portfolio by planning, executing, and optimizing omnichannel initiatives that are compliant, data‑driven, and patient‑centric. You will be required to employ creativity and have the ability to think out of the box to engage highly specialized audiences. We need a hands on, proactive, creative thinker who loves science, is analytical, and is eager to grow. You’ll manage campaigns, analyze performance, and collaborate across teams to deliver impactful, compliant marketing.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit and CSL Plasma at .